$IPCI...it's starting to make a slow move... BAZINGA>>> The CEO of Intellipharmaceutics, Dr. Isa Odidi, said, "We are very pleased, after waiting almost exactly one year since Teva received final approval, that Teva now appears to have launched its 5mg Focalin XR(R) generic in the United States. Par now manufactures, markets and distributes the 15mg and 30mg strengths of generic Focalin XR(R), and we would be pleased to see the 5mg strength added to their portfolio."
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.